AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans for mortality prediction: a multicentre study
- PMID: 40382274
- PMCID: PMC12126277
- DOI: 10.1016/j.landig.2025.02.002
AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans for mortality prediction: a multicentre study
Abstract
Background: CT attenuation correction (CTAC) scans are routinely obtained during cardiac perfusion imaging, but currently only used for attenuation correction and visual calcium estimation. We aimed to develop a novel artificial intelligence (AI)-based approach to obtain volumetric measurements of chest body composition from CTAC scans and to evaluate these measures for all-cause mortality risk stratification.
Methods: We applied AI-based segmentation and image-processing techniques on CTAC scans from a large international image-based registry at four sites (Yale University, University of Calgary, Columbia University, and University of Ottawa), to define the chest rib cage and multiple tissues. Volumetric measures of bone, skeletal muscle, subcutaneous adipose tissue, intramuscular adipose tissue (IMAT), visceral adipose tissue (VAT), and epicardial adipose tissue (EAT) were quantified between automatically identified T5 and T11 vertebrae. The independent prognostic value of volumetric attenuation and indexed volumes were evaluated for predicting all-cause mortality, adjusting for established risk factors and 18 other body composition measures via Cox regression models and Kaplan-Meier curves.
Findings: The end-to-end processing time was less than 2 min per scan with no user interaction. Between 2009 and 2021, we included 11 305 participants from four sites participating in the REFINE SPECT registry, who underwent single-photon emission computed tomography cardiac scans. After excluding patients who had incomplete T5-T11 scan coverage, missing clinical data, or who had been used for EAT model training, the final study group comprised 9918 patients. 5451 (55%) of 9918 participants were male and 4467 (45%) of 9918 participants were female. Median follow-up time was 2·48 years (IQR 1·46-3·65), during which 610 (6%) patients died. High VAT, EAT, and IMAT attenuation were associated with an increased all-cause mortality risk (adjusted hazard ratio 2·39, 95% CI 1·92-2·96; p<0·0001, 1·55, 1·26-1·90; p<0·0001, and 1·30, 1·06-1·60; p=0·012, respectively). Patients with high bone attenuation were at reduced risk of death (0·77, 0·62-0·95; p=0·016). Likewise, high skeletal muscle volume index was associated with a reduced risk of death (0·56, 0·44-0·71; p<0·0001).
Interpretation: CTAC scans obtained routinely during cardiac perfusion imaging contain important volumetric body composition biomarkers that can be automatically measured and offer important additional prognostic value.
Funding: The National Heart, Lung, and Blood Institute, National Institutes of Health.
Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests AMM received consulting fees from APQ Health. RJHM received grant support and consulting fees from Pfizer. TDR received research grant support from Siemens Medical Systems and Pfizer Global. AJE received speaker fees from Ionetix, consulting fees from W L Gore & Associates and Artrya, and authorship fees from Wolters Kluwer Healthcare–UpToDate; served on a scientific advisory board for Canon Medical Systems; and received grants from Attralus, BridgeBio, Canon Medical Systems, GE Healthcare, Mediwhale, Intellia Therapeutics, Ionis Pharmaceuticals, Neovasc, Pfizer, Roche Medical Systems, and W L Gore & Associates. EJM received grant support from Pfizer, ARGO SPECT, Alnylam, Siemens Medical Systems, and the National Institutes of Health; and consulting fees from Pfizer, Alnylam, Synektik, and Eidos–BioBridge. MB was supported by a research award from the Kosciuszko Foundation–The American Centre of Polish Culture. DSB, PBK, and PJS receive software royalties for QPS software at Cedars-Sinai Medical Center. DD, PJS, and DSB declare equity interest in APQ Health. DSB received research grant support from the Dr Miriam and Sheldon G Adelson Medical Research Foundation, and served as a consultant for GE Healthcare. PJS received research grant support from Siemens Medical Systems and consulting fees from Synektik. All other authors declare no competing interests.
Figures
Update of
-
AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans enhances mortality prediction: multicenter study.medRxiv [Preprint]. 2024 Aug 1:2024.07.30.24311224. doi: 10.1101/2024.07.30.24311224. medRxiv. 2024. Update in: Lancet Digit Health. 2025 May;7(5):100862. doi: 10.1016/j.landig.2025.02.002. PMID: 39132480 Free PMC article. Updated. Preprint.
References
-
- Al-Mallah MH, Bateman TM, Branch KR, et al. 2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging. J Nucl Cardiol 2022; 29: 3491–3535. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
